Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Capital Expenditures: 2010-2025

Historic Capital Expenditures for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $17.3 million.

  • Alkermes' Capital Expenditures rose 109.66% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.2 million, marking a year-over-year increase of 23.25%. This contributed to the annual value of $33.5 million for FY2024, which is 30.31% down from last year.
  • According to the latest figures from Q3 2025, Alkermes' Capital Expenditures is $17.3 million, which was up 33.02% from $13.0 million recorded in Q2 2025.
  • Alkermes' Capital Expenditures' 5-year high stood at $17.3 million during Q3 2025, with a 5-year trough of $4.8 million in Q3 2021.
  • For the 3-year period, Alkermes' Capital Expenditures averaged around $11.1 million, with its median value being $9.8 million (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 59.66% in 2021, then spiked by 117.62% in 2022.
  • Over the past 5 years, Alkermes' Capital Expenditures (Quarterly) stood at $8.7 million in 2021, then rose by 15.78% to $10.0 million in 2022, then surged by 69.82% to $17.0 million in 2023, then crashed by 42.61% to $9.8 million in 2024, then skyrocketed by 109.66% to $17.3 million in 2025.
  • Its last three reported values are $17.3 million in Q3 2025, $13.0 million for Q2 2025, and $10.1 million during Q1 2025.